FDA Grants Premarket Approval for the NeuroPace RNS System to Treat Medically Refractory Epilepsy

15-11-2013 Business Wire HealthComments (0)

Biotechnology

The RNS(R) System has been granted premarket approval (PMA) from the FDA for the treatment of adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top